A detailed history of Legacy Trust transactions in Eli Lilly & CO stock. As of the latest transaction made, Legacy Trust holds 1,186 shares of LLY stock, worth $1.11 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,186
Previous 1,216 2.47%
Holding current value
$1.11 Million
Previous $709 Million 30.17%
% of portfolio
0.23%
Previous 0.18%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$592.2 - $792.28 $17,766 - $23,768
-30 Reduced 2.47%
1,186 $923 Million
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $55,144 - $65,008
105 Added 9.45%
1,216 $709 Million
Q3 2023

Oct 16, 2023

SELL
$434.7 - $599.3 $6,520 - $8,989
-15 Reduced 1.33%
1,111 $597 Million
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $6,664 - $8,910
-19 Reduced 1.66%
1,126 $528 Million
Q1 2023

Apr 19, 2023

SELL
$310.63 - $364.82 $7,765 - $9,120
-25 Reduced 2.14%
1,145 $393 Million
Q4 2022

Apr 03, 2023

BUY
$321.55 - $374.67 $376,213 - $438,363
1,170 New
1,170 $428 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $893B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Legacy Trust Portfolio

Follow Legacy Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Trust, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Trust with notifications on news.